May10 FDA News: Issue 10, May 2022 US Food and Drug Administration Announces Availability of a Draft Guidance, Clinical Pharmacology... Read More.. May10 ASCPT Celebrates Asian American/Pacific Islander Heritage Month Throughout May, and every day, ASCPT recognizes and celebrates the myriad contributions of our Asia... Read More.. May05 ASCPT News: May 2022 Stay up to date on the latest in clinical pharmacology and translational science. Read More.. May01 I am ASCPT: Maria Burian Maria Burian, MBA, MD, PhD, Translational Medicine Neuroscience, SRL, Braine-l’Alleud, Belgium Read More.. May01 I am ASCPT: Matthew Riggs Matthew Riggs, PhD, Chief Science Officer, Metrum Research Group, Tarriffville, CT Read More.. May01 I am ASCPT: Deanna Kroetz Deanna L. Kroetz, PhD, Professor, University of California, San Francisco, San Francisco, CA Read More.. May01 I am ASCPT: Lakshmi Vasist Lakshmi S. Vasist, PharmD, Director, Clinical Pharmacology Modeling & Simulation, GlaxoSmithKline, C... Read More.. Apr22 FDA News: Issue 9.2, April 2022 US Food and Drug Administration Announces Availability of a Final Guidance Entitled Bioavailabili... Read More.. Apr22 FDA News: Issue 9.1, April 2022 US Food and Drug Administration and M-CERSI Announce a Two-Day Virtual Public Workshop on Pharmac... Read More.. Apr15 FDA News: Issue 8, April 2022 FDA Approves VIJOICE (Alpelisib) for the Treatment of Adult and Pediatric Patients 2 Years of Age ... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 of 49
May10 ASCPT Celebrates Asian American/Pacific Islander Heritage Month Throughout May, and every day, ASCPT recognizes and celebrates the myriad contributions of our Asia... Read More.. May05 ASCPT News: May 2022 Stay up to date on the latest in clinical pharmacology and translational science. Read More.. May01 I am ASCPT: Maria Burian Maria Burian, MBA, MD, PhD, Translational Medicine Neuroscience, SRL, Braine-l’Alleud, Belgium Read More.. May01 I am ASCPT: Matthew Riggs Matthew Riggs, PhD, Chief Science Officer, Metrum Research Group, Tarriffville, CT Read More.. May01 I am ASCPT: Deanna Kroetz Deanna L. Kroetz, PhD, Professor, University of California, San Francisco, San Francisco, CA Read More.. May01 I am ASCPT: Lakshmi Vasist Lakshmi S. Vasist, PharmD, Director, Clinical Pharmacology Modeling & Simulation, GlaxoSmithKline, C... Read More.. Apr22 FDA News: Issue 9.2, April 2022 US Food and Drug Administration Announces Availability of a Final Guidance Entitled Bioavailabili... Read More.. Apr22 FDA News: Issue 9.1, April 2022 US Food and Drug Administration and M-CERSI Announce a Two-Day Virtual Public Workshop on Pharmac... Read More.. Apr15 FDA News: Issue 8, April 2022 FDA Approves VIJOICE (Alpelisib) for the Treatment of Adult and Pediatric Patients 2 Years of Age ... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 of 49
May05 ASCPT News: May 2022 Stay up to date on the latest in clinical pharmacology and translational science. Read More.. May01 I am ASCPT: Maria Burian Maria Burian, MBA, MD, PhD, Translational Medicine Neuroscience, SRL, Braine-l’Alleud, Belgium Read More.. May01 I am ASCPT: Matthew Riggs Matthew Riggs, PhD, Chief Science Officer, Metrum Research Group, Tarriffville, CT Read More.. May01 I am ASCPT: Deanna Kroetz Deanna L. Kroetz, PhD, Professor, University of California, San Francisco, San Francisco, CA Read More.. May01 I am ASCPT: Lakshmi Vasist Lakshmi S. Vasist, PharmD, Director, Clinical Pharmacology Modeling & Simulation, GlaxoSmithKline, C... Read More.. Apr22 FDA News: Issue 9.2, April 2022 US Food and Drug Administration Announces Availability of a Final Guidance Entitled Bioavailabili... Read More.. Apr22 FDA News: Issue 9.1, April 2022 US Food and Drug Administration and M-CERSI Announce a Two-Day Virtual Public Workshop on Pharmac... Read More.. Apr15 FDA News: Issue 8, April 2022 FDA Approves VIJOICE (Alpelisib) for the Treatment of Adult and Pediatric Patients 2 Years of Age ... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 of 49
May01 I am ASCPT: Maria Burian Maria Burian, MBA, MD, PhD, Translational Medicine Neuroscience, SRL, Braine-l’Alleud, Belgium Read More.. May01 I am ASCPT: Matthew Riggs Matthew Riggs, PhD, Chief Science Officer, Metrum Research Group, Tarriffville, CT Read More.. May01 I am ASCPT: Deanna Kroetz Deanna L. Kroetz, PhD, Professor, University of California, San Francisco, San Francisco, CA Read More.. May01 I am ASCPT: Lakshmi Vasist Lakshmi S. Vasist, PharmD, Director, Clinical Pharmacology Modeling & Simulation, GlaxoSmithKline, C... Read More.. Apr22 FDA News: Issue 9.2, April 2022 US Food and Drug Administration Announces Availability of a Final Guidance Entitled Bioavailabili... Read More.. Apr22 FDA News: Issue 9.1, April 2022 US Food and Drug Administration and M-CERSI Announce a Two-Day Virtual Public Workshop on Pharmac... Read More.. Apr15 FDA News: Issue 8, April 2022 FDA Approves VIJOICE (Alpelisib) for the Treatment of Adult and Pediatric Patients 2 Years of Age ... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 of 49
May01 I am ASCPT: Matthew Riggs Matthew Riggs, PhD, Chief Science Officer, Metrum Research Group, Tarriffville, CT Read More.. May01 I am ASCPT: Deanna Kroetz Deanna L. Kroetz, PhD, Professor, University of California, San Francisco, San Francisco, CA Read More.. May01 I am ASCPT: Lakshmi Vasist Lakshmi S. Vasist, PharmD, Director, Clinical Pharmacology Modeling & Simulation, GlaxoSmithKline, C... Read More.. Apr22 FDA News: Issue 9.2, April 2022 US Food and Drug Administration Announces Availability of a Final Guidance Entitled Bioavailabili... Read More.. Apr22 FDA News: Issue 9.1, April 2022 US Food and Drug Administration and M-CERSI Announce a Two-Day Virtual Public Workshop on Pharmac... Read More.. Apr15 FDA News: Issue 8, April 2022 FDA Approves VIJOICE (Alpelisib) for the Treatment of Adult and Pediatric Patients 2 Years of Age ... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 of 49
May01 I am ASCPT: Deanna Kroetz Deanna L. Kroetz, PhD, Professor, University of California, San Francisco, San Francisco, CA Read More.. May01 I am ASCPT: Lakshmi Vasist Lakshmi S. Vasist, PharmD, Director, Clinical Pharmacology Modeling & Simulation, GlaxoSmithKline, C... Read More.. Apr22 FDA News: Issue 9.2, April 2022 US Food and Drug Administration Announces Availability of a Final Guidance Entitled Bioavailabili... Read More.. Apr22 FDA News: Issue 9.1, April 2022 US Food and Drug Administration and M-CERSI Announce a Two-Day Virtual Public Workshop on Pharmac... Read More.. Apr15 FDA News: Issue 8, April 2022 FDA Approves VIJOICE (Alpelisib) for the Treatment of Adult and Pediatric Patients 2 Years of Age ... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 of 49
May01 I am ASCPT: Lakshmi Vasist Lakshmi S. Vasist, PharmD, Director, Clinical Pharmacology Modeling & Simulation, GlaxoSmithKline, C... Read More.. Apr22 FDA News: Issue 9.2, April 2022 US Food and Drug Administration Announces Availability of a Final Guidance Entitled Bioavailabili... Read More.. Apr22 FDA News: Issue 9.1, April 2022 US Food and Drug Administration and M-CERSI Announce a Two-Day Virtual Public Workshop on Pharmac... Read More.. Apr15 FDA News: Issue 8, April 2022 FDA Approves VIJOICE (Alpelisib) for the Treatment of Adult and Pediatric Patients 2 Years of Age ... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 of 49
Apr22 FDA News: Issue 9.2, April 2022 US Food and Drug Administration Announces Availability of a Final Guidance Entitled Bioavailabili... Read More.. Apr22 FDA News: Issue 9.1, April 2022 US Food and Drug Administration and M-CERSI Announce a Two-Day Virtual Public Workshop on Pharmac... Read More.. Apr15 FDA News: Issue 8, April 2022 FDA Approves VIJOICE (Alpelisib) for the Treatment of Adult and Pediatric Patients 2 Years of Age ... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 of 49
Apr22 FDA News: Issue 9.1, April 2022 US Food and Drug Administration and M-CERSI Announce a Two-Day Virtual Public Workshop on Pharmac... Read More.. Apr15 FDA News: Issue 8, April 2022 FDA Approves VIJOICE (Alpelisib) for the Treatment of Adult and Pediatric Patients 2 Years of Age ... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 of 49
Apr15 FDA News: Issue 8, April 2022 FDA Approves VIJOICE (Alpelisib) for the Treatment of Adult and Pediatric Patients 2 Years of Age ... Read More.. Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 of 49